Diagnosis of asymptomatic natalizumab-associated PML: Are we between a rock and a hard place?

Journal of Neurology

Volumn 261, Issue 6, 2014, Pages 1139-1143

  Wattjes, Mike P ^a   Vennegoor, Anke ^a   Mostert, Jop ^b   Van Oosten, Bob W ^a   Barkhof, Frederik ^a   Killestein, Joep ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

BETA1A INTERFERON; CYCLOPHOSPHAMIDE; FINGOLIMOD; GLATIRAMER; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NATALIZUMAB; VIRUS DNA; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; ATAXIA; CASE REPORT; CASE STUDY; CEREBROSPINAL FLUID; DISEASE ACTIVITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSARTHRIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; FRONTAL LOBE; GRAY MATTER; HEMIPARESIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOADSORPTION; JC VIRUS; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TREMOR; VIRUS DETECTION; BRAIN; CHEMICALLY INDUCED; IMMUNOLOGY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 84903576252     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7336-5     Document Type: Article

References (15)

1. Rudick R, Polman C, Clifford D, Miller D et al (2013) Natalizumab: bench to bedside and beyond. JAMA Neurol 70:172-182
2. Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 80:1430-1438
3. Mentzer D, Prestel J, Adams O et al (2012) Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry 83:927-933
4. Yousry TA, Pelletier D, Cadavid D et al (2012) MRI pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 72:779-787
5. Wattjes MP, Richert ND, Killestein J et al (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826-1840
6. Blair NF, Brew BJ, Halpern JP (2012) Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance. Neurology 78:507-508
7. Havla J, Hohlfeld R, Kümpfel T (2014) Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem. J Neurol 261:232-234
8. Phan-Ba R, Lommers E, Tshibanda L et al (2012) MRI preclinical detection and asymptomatic course of a progressive multifocal leukoencephalopathy (PML) under natalizumab therapy. J Neurol Neurosurg Psychiatry 83:224-226
9. Lindå H, von Heijne A (2013) Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy. Front Neurol 4:11
10. Dong-Si T, Richman S, Bloomgren G et al (2013) Survival and functional outcome in asymptomatic natalizumab-associated progressive multifocal leukoencephalopathy multiple sclerosis patients. Mult Scler 19: (S1) P879 Presented at ECTRIMS Copenhagen, 2013
11. Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO (2010) JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 68:384-391
12. Kuhle J, Gosert R, Bühler R et al (2011) Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 77:2010-2016
13. Fine AJ, Sorbello A, Kortepeter C, Scarazzini L (2014) Progressive multifocal leukoencephalopathy after natalizumab discontinuation. Ann Neurol 75:108-115
14. Wattjes MP, Killestein J (2014) PML after natalizumab discontinuation: few and true? Ann Neurol 75:462
15. Warnke C, Markwerth P, Pawlita M et al (2013) The anti-JC virus antibody index in CSF for diagnosis of progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis. Mult Scler (S1): 181. Presented at ECTRIMS Copenhagen, 2013